1673-422X
2012 Issue 3
Gene targeting diagnosis and treatment in cancer
ZHENG Ya-bing;WANG Lin;CHANG Xiao-tian
ZHENG Ya-bing;WANG Lin;CHANG Xiao-tian
..............page:186-189
Diagnostic application value of urothelial carcinoma of the urinary bladder by dual color fluorescence in-situ hybridization
ZHANG Yu;NI Ze-chen;HU Lan-ting;ZHANG Ning;WANG Qing
ZHANG Yu;NI Ze-chen;HU Lan-ting;ZHANG Ning;WANG Qing
..............page:237-240
Variety of molecular mechanisms of cisplatin in the treatment of nasopharyngeal carcinoma
YANG Zhang-ru;WU Jing-bo
YANG Zhang-ru;WU Jing-bo
..............page:203-205
Advances of tumor-associated fibroblasts in carcinogenesis
WANG Hong-mei;XU Jun-fa
WANG Hong-mei;XU Jun-fa
..............page:163-166
Therapy of triple negative breast cancer
XU Shuai;ZHANG Xi-ping
XU Shuai;ZHANG Xi-ping
..............page:209-211
Application of nanoparticle vectors in photodynamic therapy of tumors
SHI Lei;WANG Xiu-li;WANG Hong-wei
SHI Lei;WANG Xiu-li;WANG Hong-wei
..............page:193-196
Epidermal growth factor receptor Ⅲ variant and targeted therapy of glioblastoma
YAN Hong-lian;ZHANG Long-zhen
YAN Hong-lian;ZHANG Long-zhen
..............page:200-202
Different fractionations of radiotherapy in non-small cell lung cancer
LI Jing;SONG Yu-zhi;QIAO Xue-ying
LI Jing;SONG Yu-zhi;QIAO Xue-ying
..............page:215-217
Application of epidermal growth factor receptor for radiotherapy of esophageal cancer
ZHANG He-ping;LI Jian-cheng
ZHANG He-ping;LI Jian-cheng
..............page:218-220
EMLA-ALK fusion gene in non-small cell lung cancer
HUANG Xiao-lin;CAO Zi-ang
HUANG Xiao-lin;CAO Zi-ang
..............page:212-214
Antiangiogenic therapy for PTCL
WAN Shan;GU Kang-sheng
WAN Shan;GU Kang-sheng
..............page:190-193
Function and advance of GPR30 in hormone-related neoplasms
CAI Ling-yu;HE Yin-yan;XI Xiao-wei
CAI Ling-yu;HE Yin-yan;XI Xiao-wei
..............page:166-169
Advance of the targeted anti-tumor drugs with small molecule compounds
ZHENG Jun;FAN Song-qing
ZHENG Jun;FAN Song-qing
..............page:172-175
Biological function of Securin and prospect for research in tumor
GUO Hong-yan;JIN Hui-qin;ZHANG Yun-fei;ZHANG Xi
GUO Hong-yan;JIN Hui-qin;ZHANG Yun-fei;ZHANG Xi
..............page:176-179
BRAFV600E gene mutation in papillary thyroid cancer
JIAO Xiao-ping;WANG Sheng-ying
JIAO Xiao-ping;WANG Sheng-ying
..............page:206-208
Mechanism of polarity proteins regulate tumorigenesis
ZHAO Wei;LI Xia;YUE Shu-qiang;DOU Ke-feng
ZHAO Wei;LI Xia;YUE Shu-qiang;DOU Ke-feng
..............page:179-182
Progress of the angiogenesis correlation factors for endometrial carcinoma
YAN Chun-xiao;SHENG Xiu-gui
YAN Chun-xiao;SHENG Xiu-gui
..............page:230-233
EZH2 gene and cancer
BAI Jie;SHUAI Xiao-ming;TAO Kai-xiong
BAI Jie;SHUAI Xiao-ming;TAO Kai-xiong
..............page:182-186
Molecular mechanism of cisplatin resistance in ovarian cancer
HAN Xue-chuan;FAN Yang
HAN Xue-chuan;FAN Yang
..............page:234-236
Treatment of hepatocellular carcinoma with portal vein tumor thrombus
LI Feng-e;GUO Zhi
LI Feng-e;GUO Zhi
..............page:225-227
..............page:后插2
Aminopeptidase N and its inhibitors and carcinoma
PEI Ke-ling;ZHANG Hou-li;CUI Shu-xiang
PEI Ke-ling;ZHANG Hou-li;CUI Shu-xiang
..............page:169-171,233
Helicobacter pylori and colorectal cancer
LIANG Yun-jia;CHU Yu-de;DAI De-jian
LIANG Yun-jia;CHU Yu-de;DAI De-jian
..............page:228-230
Mammalian target of rapamycin in gastric cancer
CHEN Xiao-qing;WANG Dong-xu;YUAN Hai-bin
CHEN Xiao-qing;WANG Dong-xu;YUAN Hai-bin
..............page:222-224
HMGB1 and gastric cancer
YUAN Hai-bin;WANG Dong-xu;CHEN Xiao-qing
YUAN Hai-bin;WANG Dong-xu;CHEN Xiao-qing
..............page:220-222
Radiosensitizing effect of natural active product on tumor
WANG Juan;JIN Wen-sen
WANG Juan;JIN Wen-sen
..............page:196-200